CT
RVMD icon

Clearstead Trust’s Revolution Medicines RVMD Stock Holding History

Clearstead Trust’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15K Hold
80
– – ﹤0.01% 527
2026
Q1 		$7.78K Hold
80
– – ﹤0.01% 652
2025
Q4 		$6.37K Buy
80
+27
+51% +$1.77K ﹤0.01% 701
2025
Q3 		$2.48K Buy
+53
New +$2.08K ﹤0.01% 936

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Clearstead Trust's RVMD Position: Q2 2026 in Review

Clearstead Trust held its Revolution Medicines (RVMD) position steady in Q2 2026 at 80 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #527.

Clearstead Trust first reported a position in RVMD in Q3 2025 and has held it in 4 quarters since. 688 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Clearstead Trust held 80 shares of Revolution Medicines worth $15K as of Q2 2026.
  • Clearstead Trust left its Revolution Medicines share count unchanged in Q2 2026.
  • Revolution Medicines made up ﹤0.01% of Clearstead Trust's portfolio in Q2 2026, its #527 holding.
  • Clearstead Trust first reported a position in Revolution Medicines in Q3 2025 and has held it in 4 quarters since.
  • 688 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Clearstead Trust's 13F filing for Q2 2026, filed 6 Aug 2026.